The economic value of the centers for disease control and prevention carbapenem-resistant enterobacteriaceae toolkit

Sarah M. Bartsch, Susan S. Huang, James A. McKinnell, Kim F. Wong, Leslie E. Mueller, Loren G. Miller, Bruce Y. Lee

Research output: Contribution to journalArticlepeer-review

Abstract

OBJECTIVE While previous work showed that the Centers for Disease Control and Prevention toolkit for carbapenem-resistant Enterobacteriaceae (CRE) can reduce spread regionally, these interventions are costly, and decisions makers want to know whether and when economic benefits occur.DESIGN Economic analysisSETTING Orange County, CaliforniaMETHODS Using our Regional Healthcare Ecosystem Analyst (RHEA)-generated agent-based model of all inpatient healthcare facilities, we simulated the implementation of the CRE toolkit (active screening of interfacility transfers) in different ways and estimated their economic impacts under various circumstances.RESULTS Compared to routine control measures, screening generated cost savings by year 1 when hospitals implemented screening after identifying ≤20 CRE cases (saving $2,000-$9,000) and by year 7 if all hospitals implemented in a regional coordinated manner after 1 hospital identified a CRE case (hospital perspective). Cost savings was achieved only if hospitals independently screened after identifying 10 cases (year 1, third-party payer perspective). Cost savings was achieved by year 1 if hospitals independently screened after identifying 1 CRE case and by year 3 if all hospitals coordinated and screened after 1 hospital identified 1 case (societal perspective). After a few years, all strategies cost less and have positive health effects compared to routine control measures; most strategies generate a positive cost-benefit each year.CONCLUSIONS Active screening of interfacility transfers garnered cost savings in year 1 of implementation when hospitals acted independently and by year 3 if all hospitals collectively implemented the toolkit in a coordinated manner. Despite taking longer to manifest, coordinated regional control resulted in greater savings over time. Infect Control Hosp Epidemiol 2018;39:516-524

Original languageEnglish (US)
Pages (from-to)516-524
Number of pages9
JournalInfection control and hospital epidemiology
Volume39
Issue number5
DOIs
StatePublished - May 1 2018

ASJC Scopus subject areas

  • Epidemiology
  • Microbiology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'The economic value of the centers for disease control and prevention carbapenem-resistant enterobacteriaceae toolkit'. Together they form a unique fingerprint.

Cite this